Nausea and Vomiting in Postoperative Paediatric Patients With Patient-Controlled Analgesia (PCA): Morphine vs Oxycodone
Launched by MURDOCH CHILDRENS RESEARCH INSTITUTE · Dec 16, 2023
Trial Information
Current as of September 06, 2025
Recruiting
Keywords
ClinConnect Summary
The POPCORN trial is a study designed to compare two pain relief medications, Morphine and Oxycodone, for children and young adults recovering from surgery. The main goal is to find out if one medication leads to less nausea and vomiting and if there are differences in side effects or the amount of pain relief needed. During the study, participants will be randomly assigned to receive either Morphine or Oxycodone through a method called patient-controlled analgesia (PCA), which allows them to manage their own pain relief after surgery.
To be eligible for this trial, participants need to be between the ages of 6 and 18, have had surgery, and be able to safely use the PCA system. Parents or guardians must provide consent for their child to participate. After enrolling, participants will continue to receive their usual medical care without any extra study-related activities. The healthcare team will track their progress and any side effects using the hospital's electronic medical records, which will help researchers gather important information about the medications used.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Postoperative patients who are appropriate for a PCA including those aged 6 and above and up to age 18 years.
- • Those deemed appropriate for either morphine or oxycodone by their treating anaesthetist.
- • American Society of Anaesthesiologists (ASA) score 1-3 inclusive
- • Those whose parents or legal guardians have provided informed consent on the patient's behalf.
- Exclusion Criteria:
- • Any patients with an allergy, hypersensitivity, or contraindication to morphine or oxycodone.
- • Patients in the age group with significant intellectual disability or physical incapacity rendering them incapable of using the PCA device
- • ASA score 4 or above
- • Inability or unwillingness of parent or legal guardian to provide informed consent for the study.
About Murdoch Childrens Research Institute
Murdoch Children's Research Institute (MCRI) is a leading pediatric research organization based in Australia, dedicated to improving child health through innovative research and clinical trials. With a focus on understanding and addressing the unique health challenges faced by children, MCRI collaborates with hospitals, universities, and community partners to translate research findings into practical solutions. The institute's multidisciplinary team of scientists, clinicians, and researchers is committed to advancing pediatric medicine and enhancing the quality of life for children and their families through groundbreaking studies and evidence-based interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Melbourne, Victoria, Australia
Patients applied
Trial Officials
Sue May Koh
Principal Investigator
Murdoch Childrens Research Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported